Bispecific antibodies (BsAbs) have emerged as a transformative class of biologics, offering dual-targeting mechanisms that ...

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

The following is a summary of "Bleeding Risk Assessment with Thromboelastography in Interventional Pulmonology Procedures," published in the March 2025 issue of Respiratory Medicine by Abia-Trujillo ...

Dr. Han Joong Tark's team at KERI's Nano Hybrid Technology Research Center has successfully fabricated "functional wires," ...

Haemostasis (clot formation) halts the bleeding, and the body quickly forms a blood clot in response to injury. Inflammation ...

Breast reduction surgery offers several benefits but also involves potential risks. Understanding the surgical process and possible complications can help individuals make informed decisions and ...

The company identified a new risk of injury during use of the system when patients have thick fluid in the kidney at the ...

When someone is traumatically injured, giving them blood products before they arrive at the hospital—such as at the scene or ...

The USA flocculant and coagulant market is experiencing steady growth, primarily fueled by increasing demand from municipal water treatment plants. The need for high-performance coagulation and ...

Despite advances in anticoagulant therapies, bleeding remains a critical concern.Traditionally, the definition of major ...

Dr. Han's team at KERI develops nano-based 'high-energy lightweight wire' technology. Through collaborative research with ...

XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock ...